The multiple orthogonal tools approach to define molecular causation in the validation of druggable targets

This publication has 72 references indexed in Scilit:

• Predicting drug efficacy: knockouts model pipeline drugs of the pharmaceutical industry
  Current Opinion in Pharmacology, 2003
• The multifunctional or moonlighting protein CD26/DPPIV
  European Journal of Cell Biology, 2003
• A Missense Mutation in the fabB (β-Ketoacyl-Acyl Carrier Protein Synthase I) Gene Confers Thiolactomycin Resistance to Escherichia coli
  Antimicrobial Agents and Chemotherapy, 2002
• Activating Transcription Factor 1 and CREB Are Important for Cell Survival during Early Mouse Development
  Molecular and Cellular Biology, 2002
• Use of Genetically Engineered Mice in Drug Discovery and Development: Wielding Occam's Razor to Prune the Product Portfolio
  International Journal of Toxicology, 2002
• The Value of Improving the Productivity of the Drug Development Process
  PharmacoEconomics, 2002
• Cyclosporin
  Drugs, 2001
• A single amino acid substitution in Staphylococcus aureus dihydrofolate reductase determines trimethoprim resistance 1 1 Edited by T.Richmond
  Journal of Molecular Biology, 1997
• Cyclosporin A, FK-506, and Rapamycin: Pharmacologic Probes of Lymphocyte Signal Transduction
  Annual Review of Immunology, 1992
• Effects of DL‐Alpha‐Difluoromethylornithine on Leishmania donovani Promastigotes¹
  The Journal of Protozoology, 1986